Portola Pharmaceuticals nets $131mm in initial public offering
Portola Pharmaceuticals Inc. (hematological and inflammatory disorders) has netted $131mm in its initial public offering. The company ended up selling 9.7mm shares (including the overallotment)--more than the 6.9mm planned--and priced the stock at $14.50, the mid-point of its $13-16 range.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.